Will West

CEO at CellCentric - Uttlesford, , UK

Will West's Colleagues at CellCentric
Naseer Qayum

Chief Strategy Officer

Contact Naseer Qayum

Neil Pegg

Research & Operations Director, Board Member

Contact Neil Pegg

Karen Clegg

Clinical Science Director

Contact Karen Clegg

View All Will West's Colleagues
Will West's Contact Details
HQ
+44 1799 531130
Location
United Kingdom
Company
CellCentric
Will West's Company Details
CellCentric logo, CellCentric contact details

CellCentric

Uttlesford, , UK • 38 Employees
BioTech/Drugs

Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise have few alternatives.

N/A
Details about CellCentric
Frequently Asked Questions about Will West
Will West currently works for CellCentric.
Will West's role at CellCentric is CEO.
Will West's email address is ***@cellcentric.com. To view Will West's full email address, please signup to ConnectPlex.
Will West works in the BioTech/Drugs industry.
Will West's colleagues at CellCentric are Naseer Qayum, Nigel Brooks, Neil Pegg, Andrea Vatansever, Fernanda Santos, Karen Clegg and others.
Will West's phone number is +44 1799 531130
See more information about Will West